Ambu jumps as soaring endoscopy sales drive Q1 beat

Ambu A/S

30/01/2024 08:17

** Shares in Ambu  AMBUb.CO  rise 5% after the Danish
medical equipment maker posted Q1 results above expectations,
driven by sales in endoscopy solutions growing by a fourth
    ** Ambu posts Q1 2024/25 organic sales growing 14%, 1.5 pp
ahead of consensus, per J.P. Morgan
    ** The company reports organic growth in endoscopy
solutions, its bigger unit in terms of revenue, at 25% in the
quarter
    ** JPM also notes that EBIT margin in the quarter, which
came at 10%, was 20% above consensus estimates
    ** The broker expects long single digit upgrades to EBIT
expectations 

 (Reporting by Boleslaw Lasocki)
 ((boleslaw.lasocki@thomsonreuters.com; +48 58 769 66 00;))